title: Impact of shock energy and ventricular rhythm on the success of first shock therapy: the ALTITUDE first shock study.
abstract: BACKGROUND
  The efficacy of shock in converting different ventricular tachyarrhythmias has not been well characterized in a large natural-practice setting.
  
  
  OBJECTIVE
  To determine shock success rate by energy and ventricular rhythm in a large cohort of patients with implantable cardioverter-defibrillators.
  
  
  METHODS
  Two thousand patients with 5279 shock episodes were randomly sampled for analysis from the LATITUDE remote monitoring system. Within an episode, the rhythm preceding therapy (shock or antitachycardia pacing [ATP]) was adjudicated. Patients who died after unsuccessful implantable cardioverter-defibrillator shocks did not transmit final remote monitoring data and were not included in the study.
  
  
  RESULTS
  Of 3677 shock episodes for ventricular tachyarrhythmia, 2679 were treated with shock initially and were classified as monomorphic ventricular tachycardia ( n = 1544), polymorphic/monomorphic ventricular tachycardia (n = 371), or ventricular fibrillation (n = 764). The success rate after the first, second, and final shock averaged 90.3%, 96.4%, and 99.8%, respectively. After unsuccessful initial ATP (n = 998), the first, second, and final shock was successful in 84.8%, 92.9%, and 100% of the episodes. The success rate after the first or second shock was significantly lower after failed ATP compared to shock as first therapy (both P<.001). Among episodes treated initially with shock, the success rate for monomorphic ventricular tachycardia (89.2%) when treated with energy level ≤ 20 J was significantly higher than that for ventricular fibrillation (80.8%) (P = .04). The level of shock energy was a significant predictor of the success of the first shock (odds ratio 1.16; 95% confidence interval 1.03-1.30; P = .013).
  
  
  CONCLUSIONS
  The success rate of first shock as first therapy is approximately 90%, but was lower after failed ATP. Programming a higher level of energy after ATP is suggested.
authors: Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA. ycha@mayo.edu
authors: Yong-Mei
authors: YM
authors: Cha
authors: David L
authors: DL
authors: Hayes
authors: Samuel J
authors: SJ
authors: Asirvatham
authors: Brian D
authors: BD
authors: Powell
authors: David A
authors: DA
authors: Cesario
authors: Michael
authors: M
authors: Cao
authors: F Roosevelt
authors: FR
authors: Gilliam
authors: Paul W
authors: PW
authors: Jones
authors: Songtao
authors: S
authors: Jiang
authors: Leslie A
authors: LA
authors: Saxon
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D017147:Defibrillators, Implantable; D004554:Electric Countershock; D004562:Electrocardiography; D005260:Female; D006352:Heart Ventricles / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015996:Survival Rate; D017180:Tachycardia, Ventricular / Q000503:physiopathology* / Q000628:therapy; D016896:Treatment Outcome; D014481:United States; D014693:Ventricular Fibrillation / Q000503:physiopathology* / Q000628:therapy